Global Molecular Diagnostics Partnering Terms and Agreements Report 2022 –

DUBLIN–(BUSINESS WIRE)–The “Global Molecular Diagnostics Partnering Terms and Agreements 2015 to 2022” report has been added to’s offering. Key benefits In-depth understanding of Molecular Diagnostics deal trends since 2015 Access to headline, upfront, milestone and royalty data Detailed access to actual Molecular Diagnostics contracts entered into by leading biopharma companies Identify most active Molecular … [Read more…]

Sarcoidosis Market and Epidemiology Report 2022 With Seven Major Market Analysis –

DUBLIN–(BUSINESS WIRE)–The “Sarcoidosis – Market Insight, Epidemiology and Market Forecast -2032” report has been added to’s offering. Report Highlights In the coming years, Sarcoidosis market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable … [Read more…]

Vietnam Software as a Service Market Report 2022: Infrastructure Development and Demand from Healthcare, Telecommunications and Retail Fueling Significant Growth –

DUBLIN–(BUSINESS WIRE)–The “Vietnam Software as a Service Market, By Business Application (Marketing, Customer Relationship Management, Others), By Offering, By Organization Size, By Deployment, By End User, By Region, Competition Forecast & Opportunities, 2017-2027” report has been added to’s offering. Vietnam Software as a Service market is anticipated to grow at a significant rate during … [Read more…]

European Academy of Neurology (EAN 2022) – Braintale to Present Promising Results on Amyotrophic Lateral Sclerosis Biomarker Potential of Its Digital Platform

STRASBOURG, France–(BUSINESS WIRE)–Braintale, a medtech deciphering white matter, spin off from the Paris Greater Hospitals has presented the results of SOM-ALS sub-study in amyotrophic lateral sclerosis (ALS) during the European Academy of Neurology (EAN 2022) congress both in Vienna (Austria) and digitally from June 25th to 28th, 2022. Long underestimated in neurosciences, white matter, which … [Read more…]

Global Ultra large Volume Wearable Injectors Market (2022 to 2027) – Presence of Products in the Development Phase Presents Opportunities –

DUBLIN–(BUSINESS WIRE)–The “Global Ultra large Volume Wearable Injectors Market (2022-2027) by Product, Application, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis” report has been added to’s offering. The Global Ultra large Volume Wearable Injectors Market is estimated to be USD 2.34 Bn in 2022 and is projected to reach USD 4.54 … [Read more…]

 US FDA Approves Prestige Biopharma’s IND for Phase 1/2a Trial of First-in-Class Pancreatic Cancer Treatment, PBP1510

SINGAPORE–(BUSINESS WIRE)–#CancerTreatment–Prestige Biopharma Limited, a Singapore-based biopharmaceutical company with operations in USA and South Korea, announced that the U.S. Food and Drug Administration (FDA) has approved the Phase 1/2a clinical trial of its first-in-class anti-PAUF monoclonal antibody, PBP1510 (INN: Ulenistamab), for the treatment of pancreatic cancer. The clinical trial will be conducted on patients with … [Read more…]

Trastuzumab Deruxtecan Recommended for Approval in the EU by CHMP for Patients with HER2 Positive Metastatic Breast Cancer Treated with a Prior Anti-HER2-Based Regimen

Recommendation based on DESTINY-Breast03 trial results showing Daiichi Sankyo and AstraZeneca’s trastuzumab deruxtecan reduced the risk of disease progression or death by 72% vs. trastuzumab emtansine (T-DM1) TOKYO & MUNICH–(BUSINESS WIRE)–Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) trastuzumab deruxtecan has been recommended for approval in the European Union (EU) as a monotherapy for the … [Read more…]

Transgene and BioInvent Announce Positive Progress for BT-001

The oncolytic virus BT-001 replicates in the tumor for several days and expresses the anti-CTLA-4 monoclonal antibody                                                     STRASBOURG, France & LUND, Sweden–(BUSINESS WIRE)–Regulatory News: Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on the … [Read more…]

Slingshot Biosciences, Inc. Partners With Almog Diagnostic to Distribute Synthetic Cells Throughout Israel

EMERYVILLE, CA–(BUSINESS WIRE)–SLINGSHOT BIOSCIENCES, INC., the makers of synthetic cells that bring consistent precision and accurate control to replace inconsistent blood and tissue controls for use in flow cytometry and other biotech markets, today announced they have extended their distribution channel through a new agreement with Almog Diagnostic, a private company established in 1987 and … [Read more…]